How Much Does NMN/NR Cost in Utah in 2026?

Retail Cash-Pay Pricing Across Utah

The average cash-pay price for NMN or NR in Utah sits at approximately $80 per month in 2026 for a standard once-daily oral capsule regimen. That figure reflects prescription-grade compounded formulations dispensed through Utah retail and compounding pharmacies, not over-the-counter dietary supplements.

Price Range by Source

Pricing varies depending on the dispensing channel. Independent compounding pharmacies in the Salt Lake City metro area typically charge $60 to $120 per month, with sublingual formulations trending toward the higher end of that range. Mail-order compounding pharmacies licensed to ship into Utah may offer prices between $50 and $90 per month due to lower overhead.

Over-the-counter NR supplements (sold as Niagen by ChromaDex) range from $40 to $60 per month at Utah retailers like Harmons, Smith's, and online supplement vendors. These products do not require a prescription but lack the dosing precision and purity verification of compounded formulations.

Why Prices Differ from Other States

Utah has no state-level price controls on compounded medications. Pricing is set by individual pharmacies based on raw ingredient costs, compounding complexity, and dispensing fees. States with larger compounding pharmacy networks (California, Texas, Florida) sometimes see lower per-unit costs due to volume purchasing. Utah's smaller but growing compounding market keeps prices competitive without the deep discounts found in higher-volume states.

A 2021 study by Yoshino et al. Published in Science demonstrated that 250 mg daily NMN supplementation improved muscle insulin sensitivity in premenopausal women with overweight or obesity (N=25), providing clinical rationale for physician-supervised NAD+ precursor therapy 1. This evidence base shapes how Utah clinicians approach prescribing and helps patients understand what they are paying for.

Insurance and Medicaid Coverage in Utah

No major insurance carrier in Utah covers NMN or NR in any formulation. Utah Medicaid does not cover these compounds. This applies to both the compounded prescription forms and over-the-counter supplements.

Why Insurers Don't Cover NAD+ Precursors

The core issue is regulatory classification. The FDA has not approved any NMN or NR product as a drug for a specific indication. Without an FDA-approved New Drug Application (NDA), insurers have no labeled indication against which to adjudicate claims. NMN and NR fall into a regulatory gray zone: compounded versions require a prescription, but they are not "approved drugs" in the way that, say, semaglutide or levothyroxine are.

The Endocrine Society has not issued clinical practice guidelines recommending NAD+ precursor supplementation for any specific condition 2. Without guideline endorsement and FDA approval, formulary committees at SelectHealth, Regence BlueCross BlueShield of Utah, PEHP (Public Employees Health Plan), and Molina Healthcare of Utah have no pathway to add these products.

HSA and FSA Eligibility

Compounded NMN prescribed by a licensed physician for a medical condition may qualify as an HSA- or FSA-eligible expense under IRS rules for prescription medications. Utah residents using PEHP or employer-sponsored high-deductible health plans should keep the original prescription and pharmacy receipt. The IRS requires that the compound be prescribed (not purchased over the counter as a supplement) to qualify for tax-advantaged account reimbursement.

Compounded NMN Through Utah 503A Pharmacies

Compounded nicotinamide mononucleotide is legal in Utah through state-licensed 503A pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription 3.

How 503A Compounding Works

A 503A pharmacy compounds a medication for an individual patient after receiving a prescription from a licensed prescriber. In Utah, this means a physician, nurse practitioner, or physician assistant writes a prescription specifying the NMN dose, form (capsule, sublingual, or injectable), and quantity. The pharmacy then compounds the product on-site or in a licensed sterile facility.

Utah's Division of Occupational and Professional Licensing (DOPL) oversees pharmacy licensure. Compounding pharmacies must comply with USP <795> standards for nonsterile compounding and USP <797> for sterile preparations (such as IV NAD+ formulations). Patients can verify a pharmacy's license status through the DOPL online database.

Compounded Formulations Available

Utah compounding pharmacies typically offer three NMN formulations:

| Formulation | Typical Dose | Approximate Monthly Cost | Notes | |---|---|---|---| | Oral capsule | 250-500 mg daily | $60-$100 | Most common; shelf-stable | | Sublingual lozenge | 125-250 mg daily | $80-$120 | Faster absorption; bypasses first-pass metabolism | | IV NAD+ infusion | 250-500 mg per session | $200-$400 per infusion | Clinic-administered; not home use |

IV NAD+ infusions are available at longevity clinics in Salt Lake City, Park City, and St. George. These are not the same as oral NMN, but they are part of the broader NAD+ restoration category. A typical protocol involves 1 to 4 infusions per month. At $200 to $400 per session, IV NAD+ is the most expensive access route by a wide margin.

Telehealth Prescribing in Utah

Utah permits telehealth prescribing of NMN and NR statewide. A licensed prescriber can evaluate a patient via synchronous audio-video visit and issue a prescription to any Utah-licensed pharmacy, including compounding pharmacies that ship within the state.

Utah Telehealth Regulations

Utah was among the first states to pass telehealth parity legislation. The Utah Telehealth Act (Utah Code 26-60) requires insurers to cover telehealth visits at the same rate as in-person visits, though this parity applies to the consultation, not to the prescribed compound itself. A telehealth consultation for NAD+ precursor therapy typically costs $75 to $200 for the initial evaluation and $50 to $100 for follow-up visits.

Finding a Telehealth Provider

Several national telehealth platforms now offer longevity-focused consultations that include NAD+ precursor prescribing. Utah residents should confirm that the prescribing clinician holds an active Utah medical license. The prescription must be sent to a pharmacy licensed in Utah or to a 503A pharmacy in another state that is registered to ship into Utah.

A randomized controlled trial by Martens et al. (2018) found that NR supplementation at 1,000 mg daily for 6 weeks raised NAD+ levels by approximately 60% in healthy middle-aged and older adults (N=24), with reductions in systolic blood pressure and aortic stiffness observed in participants with stage 1 hypertension 4. These findings support physician oversight of dosing, which telehealth visits can provide efficiently.

How to Reduce NMN/NR Costs in Utah

Since insurance coverage is unavailable, Utah residents must rely on cash-pay strategies to manage costs. Several approaches can reduce the effective monthly price.

Compare Compounding Pharmacies

Prices vary by 40% to 60% across Utah compounding pharmacies for the same formulation. Calling three to four pharmacies for a price quote before filling a prescription is the single most effective cost-reduction step. Mail-order compounding pharmacies often undercut local brick-and-mortar pharmacies by $10 to $30 per month.

Choose Oral Over Sublingual

Oral capsules are less expensive to compound than sublingual lozenges. Unless a clinician identifies a specific reason for sublingual delivery (such as GI absorption concerns), oral capsules at $60 to $100 per month represent the most cost-effective prescription option.

Consider OTC Nicotinamide Riboside

For patients who do not require prescription-grade compounding, over-the-counter NR (nicotinamide riboside, marketed as Niagen) offers a lower price point at $40 to $60 per month. NR and NMN are both NAD+ precursors that raise intracellular NAD+ levels through slightly different metabolic pathways. A study by Trammell et al. (2016) demonstrated dose-dependent increases in blood NAD+ with single oral doses of NR ranging from 100 to 1,000 mg in healthy volunteers 5.

The tradeoff: OTC supplements are regulated as dietary supplements under DSHEA, not as drugs. They undergo less rigorous manufacturing oversight than compounded prescriptions. Third-party testing certifications (NSF International, USP Verified, or ConsumerLab) can partially offset this concern.

Use HSA/FSA Funds

As noted above, prescription NMN compounds may be reimbursable through HSA or FSA accounts. This effectively reduces the out-of-pocket cost by the patient's marginal tax rate, a 22% to 37% discount for most Utah taxpayers.

Volume Purchasing

Some compounding pharmacies offer 90-day supply pricing at a 10% to 15% discount over monthly fills. Patients on stable doses should ask about multi-month dispensing.

NMN vs. NR: What Utah Patients Should Know

Utah patients frequently ask whether NMN or NR is the better choice. Both molecules serve as precursors to NAD+, a coenzyme required for cellular energy metabolism, DNA repair, and sirtuin activation.

Metabolic Pathway Differences

NMN (nicotinamide mononucleotide) is one step closer to NAD+ in the salvage pathway than NR (nicotinamide riboside). NMN is converted directly to NAD+ by the enzyme NMNAT. NR must first be phosphorylated to NMN by NR kinases before conversion to NAD+. Whether this one-step advantage translates to clinically meaningful differences in humans remains an open question.

Regulatory Status Differences

NR has a clearer regulatory path as a dietary supplement. ChromaDex's Niagen (NR) holds FDA Generally Recognized as Safe (GRAS) status and is sold over the counter nationwide. NMN's supplement status became complicated in 2022 when the FDA initially questioned whether NMN could be marketed as a dietary supplement due to its investigation as a new drug. That regulatory ambiguity has increased demand for compounded NMN through 503A pharmacies, which operate under drug compounding law rather than supplement regulations.

In Utah, both NR supplements and compounded NMN are legally available. The choice often comes down to whether a patient prefers the convenience and lower cost of OTC NR or the dosing precision and physician oversight of compounded NMN.

Clinical Evidence Comparison

A head-to-head comparison of NMN and NR in humans has not been published as of mid-2026. The most cited NMN trial remains Yoshino et al. (2021), which used 250 mg daily 1. The most cited NR trial is Martens et al. (2018), which used 1,000 mg daily 4. Both demonstrated NAD+ elevation and downstream physiological effects, but direct efficacy comparison across trials is methodologically unreliable due to different populations, doses, and endpoints.

Safety and Monitoring Considerations

NAD+ precursor therapy is generally well tolerated in published trials. The Yoshino et al. Trial reported no serious adverse events at 250 mg NMN daily over 10 weeks 1. Martens et al. Reported no serious adverse events at 1,000 mg NR daily over 6 weeks 4.

Common Side Effects

Mild GI symptoms (nausea, bloating, diarrhea) occur in a minority of patients, typically during the first 1 to 2 weeks. Flushing has been reported with higher NMN doses, likely related to downstream nicotinamide metabolism. These effects are generally self-limiting.

Monitoring Recommendations

No consensus monitoring protocol exists for NAD+ precursor therapy. Clinicians who prescribe NMN or NR in Utah typically order baseline and follow-up labs that include a comprehensive metabolic panel, liver function tests, and fasting glucose. Some longevity-focused practices also measure intracellular NAD+ levels through specialized reference labs, though the clinical utility of this measurement has not been validated in guidelines.

Patients taking concurrent medications should discuss potential interactions with their prescriber. NAD+ metabolism intersects with pathways affected by metformin, rapamycin, and certain chemotherapeutic agents 6. A 2018 review by Rajman et al. In Cell Metabolism mapped these intersections and recommended clinical caution when combining NAD+ boosters with mTOR inhibitors or PARP inhibitors 6.

Utah-Specific Access Summary

Utah residents have straightforward access to NMN and NR through multiple channels. The practical decision tree looks like this:

| Priority | Best Option | Approximate Monthly Cost | |---|---|---| | Lowest cost, no Rx needed | OTC nicotinamide riboside (Niagen) | $40-$60 | | Prescription-grade, oral | Compounded NMN capsule via 503A pharmacy | $60-$100 | | Sublingual delivery | Compounded NMN sublingual via 503A pharmacy | $80-$120 | | Maximum bioavailability | IV NAD+ clinic infusion (Salt Lake City, Park City, St. George) | $200-$400/session |

All prescription options require evaluation by a Utah-licensed prescriber, available via in-person visit or telehealth. The state imposes no unique restrictions on NAD+ precursor prescribing beyond standard prescribing authority requirements.